Rive Sarfstein

Tel Aviv, TA 69978, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

RETRACTED: Sarfstein et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. Cancers 2010, 2, 233-261.

RETRACTED: Sarfstein et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. Cancers 2010, 2, 233-261.

Journal: Cancers
Published: October 08, 2025

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.

Journal: Cells
Published: August 28, 2022

Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.

Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.

Journal: Cells
Published: April 04, 2022

MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.

MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.

Journal: International journal of molecular sciences
Published: October 10, 2021

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.

Journal: Cells
Published: May 04, 2021

ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.

ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.

Journal: Frontiers in endocrinology
Published: March 30, 2021

Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127].

Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127].

Journal: European journal of cancer (Oxford, England : 1990)
Published: March 17, 2021

The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.

The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.

Journal: Biomolecules
Published: March 01, 2021

Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.

Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.

Journal: Cells
Published: October 18, 2020

Identification of nephronectin as a new target for IGF1 action.

Identification of nephronectin as a new target for IGF1 action.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 03, 2020

Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter.

Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter.

Journal: Oncotarget
Published: April 14, 2020

Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.

Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.

Journal: Frontiers in endocrinology
Published: February 18, 2020
Showing 1-12 of 33

Last Updated: 09/26/2026